Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling
出版年份 2018 全文链接
标题
Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling
作者
关键词
Uterine cancer, Small interfering RNAs, Transcription factors, Mouse models, Cancer cell migration, Estrogens, Cancer treatment, Gene expression
出版物
PLoS One
Volume 13, Issue 12, Pages e0208351
出版商
Public Library of Science (PLoS)
发表日期
2018-12-27
DOI
10.1371/journal.pone.0208351
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer
- (2018) Ken-ichi Takayama et al. ONCOGENE
- An Integrated Systems Biology Approach Identifies TRIM25 as a Key Determinant of Breast Cancer Metastasis
- (2017) Logan A. Walsh et al. Cell Reports
- Blocking NF- B Is Essential for the Immunotherapeutic Effect of Recombinant IL18 in Pancreatic Cancer
- (2016) X. Guo et al. CLINICAL CANCER RESEARCH
- Overexpression of TRIM25 in Lung Cancer Regulates Tumor Cell Progression
- (2016) Ying Qin et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF-β signaling
- (2016) Zhenya Zhu et al. Scientific Reports
- Interleukin-18 enhances breast cancer cell migration via down-regulation of claudin-12 and induction of the p38 MAPK pathway
- (2015) Yoolhee Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy
- (2015) Yuji Ikeda et al. BRITISH JOURNAL OF CANCER
- TRIM25 has a dual function in the p53/Mdm2 circuit
- (2015) P Zhang et al. ONCOGENE
- The therapeutic significance of aromatase inhibitors in endometrial carcinoma
- (2014) Chao Gao et al. GYNECOLOGIC ONCOLOGY
- Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor
- (2014) Brent J. Tierney et al. GYNECOLOGIC ONCOLOGY
- Oestrogen causes ATBF1 protein degradation through the oestrogen-responsive E3 ubiquitin ligase EFP
- (2012) Xue-Yuan Dong et al. BIOCHEMICAL JOURNAL
- 14-3-3σ mediates G2–M arrest produced by 5-aza-2′-deoxycytidine and possesses a tumor suppressor role in endometrial carcinoma cells
- (2012) Michael Steiner et al. GYNECOLOGIC ONCOLOGY
- Oestrogen causes degradation of KLF5 by inducing the E3 ubiquitin ligase EFP in ER-positive breast cancer cells
- (2011) Ke-Wen Zhao et al. BIOCHEMICAL JOURNAL
- Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells
- (2011) Alexandre Rouette et al. INTERNATIONAL JOURNAL OF CANCER
- Knockdown of Efp by DNA-modified small interfering RNA inhibits breast cancer cell proliferation and in vivo tumor growth
- (2010) K Ueyama et al. CANCER GENE THERAPY
- Inflammatory events in endometrial adenocarcinoma
- (2010) Alison E Wallace et al. JOURNAL OF ENDOCRINOLOGY
- Inflammation and Cancer: IL-6 and STAT3 Complete the Link
- (2009) Jacqueline Bromberg et al. CANCER CELL
- Influenza A Virus NS1 Targets the Ubiquitin Ligase TRIM25 to Evade Recognition by the Host Viral RNA Sensor RIG-I
- (2009) Michaela Ulrike Gack et al. Cell Host & Microbe
- IL-1, IL-18, and IL-33 families of cytokines
- (2008) William P. Arend et al. IMMUNOLOGICAL REVIEWS
- Analysis of protein kinase C delta (PKCδ) expression in endometrial tumors
- (2007) Elaine M. Reno et al. HUMAN PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More